Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
The Journal of Headache and Pain|August 23, 2023
Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatmentDawn C Buse, Patricia Pozo-Rosich, Laure Dupont-Benjamin, et al.
The British Journal of Ophthalmology|May 2, 2019
Individuals with migraine have a different dry eye symptom profile than individuals without migraineMonika Farhangi, Ryan J Diel, Dawn C Buse, et al.
Headache|July 2, 2013
Effects of switching acute treatment on disability in migraine patients using triptansDaniel Serrano, Dawn C Buse, Shashi H Kori, et al.
Headache|February 9, 2022
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trialsAriane K Kawata, Mary Kate Ladd, Richard B Lipton, et al.
Headache|August 15, 2019
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Cephalalgia : an International Journal of Headache|February 9, 2019
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) studyDavid W Dodick, Michael L Reed, Kristina M Fanning, et al.
Headache|October 21, 2018
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender DifferencesRichard B Lipton, Sagar Munjal, Aftab Alam, et al.
The Journal of Headache and Pain|May 26, 2018
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) studyTodd J Schwedt, Aftab Alam, Michael L Reed, et al.
Headache|February 3, 2016
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based SurveyAndrew Messali, Joanna C Sanderson, Andrew M Blumenfeld, et al.
The Journal of Headache and Pain|February 26, 2020
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR studyRichard B Lipton, Louise Lombard, Dustin D Ruff, et al.
Pageof 23